The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease

被引:28
|
作者
Small, DH
Williamson, T
Reed, G
Clarris, H
Beyreuther, K
Masters, CL
Nurcombe, V
机构
[1] UNIV MELBOURNE,DEPT ANAT & CELL BIOL,PARKVILLE,VIC 3052,AUSTRALIA
[2] MENTAL HLTH RES INST,PARKVILLE,VIC 3052,AUSTRALIA
[3] UNIV HEIDELBERG,CTR MOLEC BIOL,W-6900 HEIDELBERG,GERMANY
来源
关键词
D O I
10.1111/j.1749-6632.1996.tb34439.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The hallmark of Alzheimer's disease (AD) is the deposition of amyloid plaques and neurofibrillary tangles in the brain. The relationship between amyloid deposition and the cognitive deficit is still unclear. The amyloid beta A4 protein is produced by proteolytic cleavage of the amyloid protein precursor (APP). Very Little is known about the normal function of APP and the role the protein may play in pathogenesis. Several studies have shown that APP is important for the regulation of neurite outgrowth. Our studies support these findings and indicate that the neurite outgrowth-promoting effects of APP are stimulated by an interaction between APP and specific proteoglycans. Using site-directed mutagenesis, a heparan sulfate binding site which mediates this effect has been mapped to the N-terminus of APP (residues 96-110, HBD-1). A peptide homologous to HBD-1 blocks the trophic effects of APP in cell culture. To purify specific proteoglycans which stimulate the action of APP, an affinity column was constructed using a biotinylated peptide homologous to HBD-1 coupled to streptavidin-agarose. Two proteoglycans were isolated from a crude brain cell conditioned medium by affinity chromatography. The purified proteoglycans bound APP saturably with high affinity and stimulated the action of APP on neurite outgrowth from chick sympathetic neurons. Digestion of the proteoglycan fraction with heparitinase I or chondroitinase ABC demonstrated the presence of two major proteins, a heparan sulfate proteoglycan with a core protein of 63-67 kD molecular mass and a chondroitin sulfate proteoglycan with a core protein of 100-110 kD molecular mass. The results demonstrate that APP binds to at least two proteoglycans and that this interaction may regulate the trophic effects of the protein. The interaction of specific APP-binding proteoglycans with amyloid plaques may disturb the normal function of APP and contribute to the neuritic degeneration that is commonly seen around the amyloid plaque cores.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
  • [1] The distribution of heparan sulfate proteoglycans in Alzheimer's disease brains
    van Horssen, J
    Otte-Holler, I
    Maass, C
    Wesseling, P
    de Waal, R
    Verbeek, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S486 - S486
  • [2] Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer's Disease
    Zhang, Gan-lin
    Zhang, Xiao
    Wang, Xiao-min
    Li, Jin-Ping
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Further evidence implicating perlecan and other heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow, AD
    Castillo, GM
    Cummings, J
    Ngo, C
    Maresh, G
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S259 - S259
  • [4] Study of the expression of part-time heparan sulfate proteoglycans in Alzheimer's disease
    Lorente Gea, L.
    Garcia, B.
    Martin, C.
    Garcia-Suarez, O.
    Ordiales, H.
    Merayo-Lloves, J.
    Quiros, L. M.
    Fernandez-Vega, I.
    VIRCHOWS ARCHIV, 2017, 471 : S214 - S215
  • [5] Heparan sulfate proteoglycans and heparanases in Alzheimer's disease:current outlook and potential therapeutic targets
    Laura Lorente-Gea
    Beatriz García
    Carla Martín
    Luis M.Quirós
    Iván Fernández-Vega
    Neural Regeneration Research, 2017, (06) : 914 - 915
  • [6] Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer′s disease
    Fernandez-Vega, Ivan
    Lorente-Gea, Laura
    Martin, Carla
    Quiros, Luis M.
    NEURAL REGENERATION RESEARCH, 2021, 16 (07) : 1404 - 1405
  • [7] Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
    Lorente-Gea, Laura
    Garcia, Beatriz
    Martin, Carla
    Quiros, Luis M.
    Fernandez-Vega, Ivan
    NEURAL REGENERATION RESEARCH, 2017, 12 (06) : 914 - 915
  • [8] Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer′s disease
    Iván Fernández-Vega
    Laura Lorente-Gea
    Carla Martín
    Luis M.Quirós
    NeuralRegenerationResearch, 2021, 16 (07) : 1404 - 1405
  • [9] Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis
    Koganti, Raghuram
    Memon, Abdullah
    Shukla, Deepak
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (03): : 283 - 294
  • [10] Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains
    Lorente-Gea, Laura
    Garcia, Beatriz
    Martin, Carla
    Ordiales, Helena
    Garcia-Suarez, Olivia
    Pina-Batista, Kelvin M.
    Merayo-Lloves, Jesus
    Quiros, Luis M.
    Fernandez-Vega, Ivan
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (05): : 474 - 483